Muutke küpsiste eelistusi

AIDS at a Crossroads: How Antiretrovirals and Community Transformed the HIV Response [Pehme köide]

Edited by (President/CEO, International Association of Providers of AIDS Care (IAPAC), President/CEO, Fast-Track Cities Institute, and Fast-Track Health, Washington, DC, USA), Edited by , Edited by (Professor, Department of Health Behavior and Health Equity, School of )
  • Formaat: Paperback / softback, 336 pages, kõrgus x laius: 246x171 mm
  • Ilmumisaeg: 18-Jun-2026
  • Kirjastus: Oxford University Press
  • ISBN-10: 0198837011
  • ISBN-13: 9780198837015
Teised raamatud teemal:
  • Pehme köide
  • Hind: 45,59 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 56,99 €
  • Säästad 20%
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Paperback / softback, 336 pages, kõrgus x laius: 246x171 mm
  • Ilmumisaeg: 18-Jun-2026
  • Kirjastus: Oxford University Press
  • ISBN-10: 0198837011
  • ISBN-13: 9780198837015
Teised raamatud teemal:
Building upon the early history of the HIV pandemic laid out in the 2008 book A Decade of HAART, this book explores the scientific breakthroughs and global response to the HIV pandemic from the mid-1990s through 2023.

AIDS at a Crossroads: How Antiretrovirals and Community Transformed the HIV Response chronicles the global HIV response through 2023, and the remarkable progress achieved toward epidemic control through innovation in biomedicine, the resolve of political leadership, and the steadfast commitment of communities on the frontlines of the HIV response. In this sequel to A Decade of HAART: The Development and Global Impact of Highly Active Antiretroviral Therapy (2008), leading voices in HIV medicine and global health chronicle how innovation in biomedicine, political will, and community leadership together transformed the trajectory of the HIV pandemic.

This timely volume captures the extraordinary progress toward epidemic control achieved through antiretroviral therapy, pre-exposure prophylaxis, and the validation of treatment as prevention, while candidly assessing the stigma, inequities, and policy failures that persist. Written during the COVID-19 pandemic, the book includes initial insights into the colliding pandemic's shock on health systems and how this novel public health threat tested the resilience of HIV responses everywhere. New political and fiscal shocks in 2025 - precipitated by the Trump administration's HIV and global health policy reversals and funding cuts - now threaten this progress in the United States and beyond.

Divided into three sections spanning biomedical innovation, country case studies, and strategies for achieving the goal of ending AIDS as a public health threat, AIDS at a Crossroads offers historical reflection on a public health success yet to be attained and an urgent warning that controlling, eliminating, and ultimately eradicating the HIV pandemic will depend as much on scientific breakthroughs as on sustained political will and community leadership.
Dr. José M. Zuniga is President/CEO of the International Association of Providers of AIDS Care (IAPAC), Fast-Track Cities Institute, and Fast-Track Health. He is the former Chair of the Joint United Nations Programme on HIV/AIDS (UNAIDS) Task Force on Urban Health, and the Lancet-HIV Commission on the Future of Urban HIV Responses. He is Editor Emeritus of the Journal of the International Association of Providers of AIDS Care and serves on the Editorial Advisory Board of the International Journal of HIV/AIDS Prevention, Education, and Behavioural Science. Dr. Zuniga routinely advises United Nations health agencies, including the World Health Organization (WHO) and its regional offices, as well as bilateral institutions such as the US President's Emergency Plan for AIDS Relief (PEPFAR). He is a member of the American Public Health Association (USA), the National Hispanic Medical Association (USA), and Senior Associate Member of the Royal Society of Medicine (UK).

Dr. K. Rivet Amico is a Professor in the Department of Health Behavior and Health Equity at the University of Michigan's School of Public Health. She is an active contributor in the areas of HIV prevention and treatment, social-behavioural theory development, intervention implementation, and intervention evaluation and measurement. Her research includes work with engagement in HIV care, pre-exposure prophylaxis (PrEP), and social structural factors influencing health and well-being in communities affected by the HIV epidemic. She uses mixed methods, implementation science, and program development principles in her work to advance the reach and quality of care and prevention services. Dr. Amico has strong interests in research design, implementation science, program evaluation and community capacity sharing with youth, pregnant and breast-feeding women, and LGBTQI+ communities in the United States and sub-Saharan Africa.

Mx. Corey Prachniak is a lawyer who serves as Director of Health Equity at CenterLink, where they direct HealthLink, a program that supports LGBTQI+ community centers worldwide. They have a strong background in LGBTQI+ health and public health advocacy, including in their prior role as Senior Advisor on Public Health at the International Association of Providers of AIDS Care (IAPAC), leading research initiatives on urban HIV epidemics and LGBTQI+ health equity. Mx. Prachniak has also held positions at the Commonwealth of Massachusetts, Harvard University, Deloitte Consulting LLP, and other organizations, contributing to research and advocacy efforts in the fields of healthcare technology, human rights, and reproductive rights. They were admitted to the bar in the State of Maryland in 2013 and the Commonwealth of Massachusetts in 2015.